Dexter · Financial Research

The Nuclear Energy Trade

Top US nuclear & nuclear-component stocks for the coming months — with P/E, market cap, latest earnings & analyst targets, ranked across large, mid & small cap.

Horizon Mid-2026 Data as of Close May 29, 2026 Coverage Utilities · Uranium · Enrichment · SMR · Components · ETFs Class Research / Education
⚠ Research & education only — NOT personalized financial advice. All prices, valuations and targets are approximate, sourced primarily from stockanalysis.com at the May 29 2026 close plus secondary earnings coverage, and move intraday. Nuclear is one of the most volatile, narrative-driven trades in the market — position sizing matters more than picking. Verify against primary SEC filings & live quotes before any decision.
The Setup

Why nuclear is the trade of the cycle

Nuclear went from "green-energy curiosity" to "the only physics that solves the AI power problem." Four reinforcing tailwinds:

AI / datacenter demand

Hyperscalers signing 20-yr PPAs directly with nuclear operators — Microsoft/Constellation, Amazon/Talen (1,920 MW), Meta/Oklo (up to 1.2 GW). US datacenter demand → ~35 GW by 2030.

⛏️

Uranium supply deficit

Spot topped $100/lb in Jan 2026, sits ~$86–87 now, long-term ~$93. US output down ~44% YoY; Russian-import bans add a friend-shoring premium.

🏛️

Government checks

Jan 2026 DOE $2.7B enrichment plan (Centrus, General Matter, Orano) — largest federal fuel commitment since the Cold War. Uranium back on the Critical Minerals list.

⚛️

SMRs hit permits

TVA filed the first US SMR construction permit (GE Vernova BWRX-300); NANO filed its KRONOS CPA; Oklo entered DOE advanced negotiations.

The catch: much is already priced in. SMR developers are pre-revenue with multi-year timelines (Oklo's first powerhouse ~2027–2030). The trade is real but crowded — treat dips as the friend, parabolic runs as the enemy.

LARGE CAP> $10B · The cash-flowing core

01Blue chips that survive a sentiment reset

1
CEG
Constellation Energy · Nasdaq
Nuclear utility / IPPBuy · 21 analysts
Price
$287.75
Mkt Cap
$103.9B
P/E (TTM)
24.6
Fwd P/E
24.5
EPS (TTM)
$11.71
Avg Target
$365.73 +27%
52-wk
$243–413
Latest QQ1'26 (May 11): revenue $11.12B BEAT (+64% YoY on Calpine); Adj. EPS $2.74 vs $2.59 est BEAT. FY26 EPS guide reaffirmed $11–12.
ThesisLargest US carbon-free generator; signed 20-yr Microsoft PPA. Lowest-risk way to own the AI-power thesis with real cash flows & no construction risk.
RiskFERC friction on behind-the-meter datacenter deals; rich valuation; rate-sensitive.
2
GEV
GE Vernova · NYSE
Reactor / equipment (BWRX-300)Buy · 35 analysts
Price
$968.32
Mkt Cap
$260.2B
P/E (TTM)
28.3*
Fwd P/E
52.4
EPS (TTM)
$34.17*
Avg Target
$1,217 +26%
52-wk
$459–1182
Latest QQ1'26 (Apr 22): revenue $9.34B BEAT (+17%); Adj. EPS $2.01 vs $1.67 BEAT; orders $18.3B (+71%). Raised FY26 revenue to $44.5–45.5B.
ThesisGE Hitachi BWRX-300 is the SMR utilities are actually permitting (TVA Clinch River). "Picks & shovels" — wins on the buildout regardless of which developer leads.
Note* TTM EPS flattered by a one-time ~$4.0B Prolec gain — the ~52× forward P/E is the cleaner read. Nuclear is a small slice of a $260B co.
3
CCJ
Cameco · NYSE
Uranium miner + fuel cycleBuy · 24 analysts
Price
$112.70
Mkt Cap
$48.9B
P/E (TTM)
~105
Fwd P/E
~80
EPS (TTM)
$1.07
Avg Target
$130.25 +16%
52-wk
$57.6–135
Latest QQ1'26 (May 5): revenue $845M BEAT (+7%); Adj. EPS $0.47; net earnings $131M (~2× YoY); Adj. EBITDA +44%.
ThesisWorld's #2 producer (~17% of mine supply) + Westinghouse stake. Institutional-grade uranium proxy — owns the deficit without junior-miner risk.
RiskVery rich (~105× trailing); operational hiccups (it's had them); uranium-price reversal.
4
TLN
Talen Energy · Nasdaq
Nuclear IPP (Amazon deal)Buy · 16 analysts
Price
$386.80
Mkt Cap
$17.6B
P/E (TTM)
N/A
Fwd P/E
17.5
EPS (TTM)
–$0.46
Avg Target
$475.37 +23%
52-wk
$239–451
Latest QQ1'26 (May 5): revenue $1.12B BEAT; Adj. EBITDA $473M; Adj. FCF $350M. FY26 EBITDA outlook held $1.75–2.05B; $100M buyback.
ThesisSusquehanna nuclear powers an Amazon AWS campus (1,920 MW through 2042). Highest-torque large cap on the hyperscaler-PPA theme.
RiskGAAP-unprofitable on TTM (forward-profitable); concentrated assets; FERC co-location ruling risk; high beta.
5
VST
Vistra · NYSE
IPP with nuclear (AWS, Meta)Strong Buy · 19
Price
$160.23
Mkt Cap
$54.0B
P/E (TTM)
27.0
Fwd P/E
17.4
EPS (TTM)
$5.92
Avg Target
$225.29 +41%
52-wk
$133–220
Latest QQ1'26 (May 7): revenue $5.64B; EPS $2.89 vs $1.94 est BEAT (+49%); Adj. EBITDA $1.49B. Reaffirmed FY26 Adj. EBITDA $6.8–7.6B.
ThesisLargest US unregulated power producer (~44 GW); nuclear PPAs with AWS & Meta. Best AI-power generalist + aggressive buybacks; highest avg-target upside in the large caps.
RiskMore gas-weighted than a pure nuclear play; merchant-price exposure.
MID CAP$2B–$10B · The torque zone

02More leverage to each catalyst

1
OKLO
Oklo Inc. · NYSE
SMR / microreactorBuy · 23 analysts
Price
$66.88
Mkt Cap
$11.6B*
P/E (TTM)
N/A
EPS (TTM)
–$0.83
Revenue
$0 pre-rev
Avg Target
$88.89 +33%
52-wk
$45–194
Latest QQ1'26 (May 12): revenue $0; net loss $33.1M; EPS –$0.19 matched est. Cash & securities $2.54B. Stock dropped on the print.
ThesisAurora fast reactor (75 MWe); ~14 GW pipeline (Switch, Meta up to 1.2 GW), DOE Surplus Plutonium talks, Centrus HALEU JV. Highest beta to SMR catalysts.
Risk* clears $10B Pre-revenue; first powerhouse ~2027–2030; valuation is pure narrative; brutal drawdowns. The trade, not the investment.
2
BWXT
BWX Technologies · NYSE
Reactor components / fuelBuy · 14 analysts
Price
$195.88
Mkt Cap
$17.95B*
P/E (TTM)
52.2
Fwd P/E
41.1
EPS (TTM)
$3.75
Avg Target
$239.27 +22%
52-wk
$123–242
Latest QQ1'26 (May 4): revenue $860M BEAT (+26%); Adj. EPS $1.12 vs $0.92 BEAT; backlog $8.65B (+77% YoY). Raised FY26: rev >$3.75B, adj EPS $4.60–4.75.
ThesisNaval reactors + GE Vernova's first qualified BWRX-300 supplier + DOE fuel contracts. The profitable, government-backed "arms dealer" of nuclear — best risk-adjusted growth name.
Risk* clears $10B Defense/government concentration; lofty multiple; capacity-expansion execution.
3
UEC
Uranium Energy Corp · NYSE Amer
US uranium miner (ISR)Strong Buy · 9
Price
$13.77
Mkt Cap
$6.75B
P/E (TTM)
N/A
EPS (TTM)
–$0.18
Revenue
$20.2M
Avg Target
$19.17 +39%
52-wk
$5.6–20.3
Latest QFiscal Q2 (Mar 10): revenue $20.2M — sold 200K lbs U₃O₈ at $101/lb vs $80.76 spot; net loss $13.9M, EPS –$0.03 matched. ~$818M liquid assets, no debt.~2.5mo old · next ~Jun 12
ThesisDomestic Wyoming/Texas ISR producer, largely unhedged. Pure-play on US production restart + friend-shoring premium; more spot leverage than Cameco.
RiskProduction-ramp risk; unhedged = full downside if uranium reverses; thinner margins than CCJ.
4
LEU
Centrus Energy · NYSE Amer
Enrichment / HALEUBuy · 16 analysts
Price
$182.47
Mkt Cap
$3.59B
P/E (TTM)
64.1
Fwd P/E
71.6
EPS (TTM)
$2.85
Avg Target
$278.64 +53%
52-wk
$118–464
Latest QQ1'26 (May 6): revenue $76.7M (+5%); EPS $1.05 vs $0.33 BEAT; Technical Solutions +47% on HALEU. Raised FY26 revenue to $450–500M.
ThesisSelf-described only HALEU enricher in the Western world; $900M DOE award, ~$3.8B backlog to 2040. Near-monopoly in the most policy-protected choke point — biggest implied upside in the universe.
RiskCapital-intensive scale-up; timeline risk to the 2029 cascade; volatile (52-wk high $464).
5
SMR
NuScale Power · NYSE
SMR developerHold · 17 analysts
Price
$12.67
Mkt Cap
$4.63B
P/E (TTM)
N/A
EPS (TTM)
–$1.82
Revenue
$18.7M
Avg Target
$15.36 +21%
52-wk
$8.9–57.4
Latest QQ1'26 (May 7): revenue $565K MISS (–95.5% YoY on late-2025 project completions); net loss $46.7M; LPS $0.14 vs $0.13 slight miss. Liquidity ~$1.0B.
ThesisFirst & only NRC-design-approved SMR (77 MWe module). Owns the regulatory moat the others are chasing. Target range ~$7 (Citi/Sell) to ~$19+ (Northland).
RiskHistory of cancelled projects (UAMPS); heavy cash burn; needs a firm domestic order to justify the cap — hence the Hold consensus.
SMALL CAP< $2B · High-risk / high-reward

03Speculative — size accordingly

1
NNE
NANO Nuclear Energy · Nasdaq
Microreactor + HALEU transportBuy · 4 (thin)
Price
$28.88
Mkt Cap
$1.50B
P/E (TTM)
N/A
EPS (TTM)
–$0.69
Revenue
$0 pre-rev
Avg Target
$46.67 +62%
52-wk
$19–61
Latest QFiscal Q2 (May 14): net loss $9.2M; cash $569M. Milestone: KRONOS microreactor construction permit application filed with the NRC — first commercially-ready microreactor at this stage.
ThesisTwo shots on goal — reactor IP (KRONOS/ZEUS/LOKI) and Advanced Fuel Transportation, the HALEU-logistics monopoly the whole SMR sector will need.
RiskPre-revenue; extreme volatility (off Oct highs); dilution-prone; only 4 analysts cover it.
2
LTBR
Lightbridge · Nasdaq
Advanced nuclear fuelNo consensus
Price
$11.48
Mkt Cap
$377M
P/E (TTM)
N/A
EPS (TTM)
–$0.77
Revenue
$0 pre-rev
Avg Target
n/a
52-wk
$9.8–31
Latest QQ1'26 (~Apr 27): revenue $0; net loss $6.3M; cash/working capital ~$215.7M; raised $18.6M via equity. Patent allowances (US/CA/EPO), Stern Labs testing, $6M DOE/Penn State initiative.
ThesisMetallic Zr-U fuel claiming a 17% power uprate + safety benefits that could streamline SMR licensing. Asymmetric fuel-innovation lottery ticket — small $ downside, large optionality.
RiskTiny, pre-commercial, cash-burning; binary on testing outcomes; serial dilution; beta ~2.2; no analyst coverage/target.
3
URNJ / basket
Uranium juniors · ETF or DNN · EU · UUUU
Junior minersDiversified
WhyRather than anchor a third pick on a single thin micro-cap, the cleaner sub-$2B exposure is the URNJ junior-miner ETF (~$414M AUM, ~+62% 1-yr) or a basket of US ISR juniors — Denison (DNN), enCore (EU), Energy Fuels (UUUU). Verify individual caps live; several that were <$2B in late 2025 have re-rated.
Diversified Exposure

ETFs — often the smarter vehicle

For most people, an ETF beats stock-picking in a trade this volatile and headline-driven. Pure uranium-miner funds led the broader nuclear baskets over the past year.

ETF~Price~AUMExpenseTop Holding1-YrDiv Yld
URAGlobal X Uranium$50.76$6.96B0.69%Cameco ~23.2%+61.8%4.11%
URNMSprott Uranium Miners$61.28$2.19B0.75%Cameco ~21.4%+52.2%2.85%
URNJSprott Junior Uranium$28.23$413.6M0.80%Paladin ~15.7%+62.4%5.88%
NLRVanEck Uranium & Nuclear$133.30$4.87B0.52%Constellation ~8.1%+37.1%2.38%
NUKZRange Nuclear Renaissance$72.33$881.1M0.85%Cameco ~9.0%+42.5%0.80%

URA = the liquid default. URNM/URNJ = purer uranium-price / junior leverage. NUKZ = broadest whole-chain basket, but sub-$1B AUM is a liquidity cliff in a selloff.

Watchlist

Honorable mentions

Dominion (D) — regulated utility w/ nuclear + Virginia datacenter load · X-Energy — advanced SMR/TRISO fuel, watch for a listing catalyst · Energy Fuels (UUUU) — US uranium + rare-earths optionality · Kazatomprom (KAP) — world's #1 producer (ADR/geopolitical caveats) · Denison (DNN) & enCore (EU) — uranium juniors · General Matter & Orano — the other two DOE $2.7B enrichment grantees · restart plays around Three Mile Island / Palisades.

Dexter's Read

TL;DR

Own with cash flows

CEG → then GEV / BWXT for picks & shovels. Profitable, real backlogs — survive a sentiment reset.

Own the deficit

CCJ (safe) / UEC (torque) / URAURNM (diversified) for the uranium price.

Own the choke point

LEU — Western HALEU near-monopoly + $900M DOE; the biggest implied upside (+53%).

Speculate, don't anchor

OKLO · SMR · NNE · LTBR — pre-revenue, multi-year, N/A P/E. Tranche in on weakness; never chase green candles.

Biggest thesis risk

FERC rulings on behind-the-meter hyperscaler deals, a uranium reversal, and the gap between SMR headlines and SMR megawatts on the grid.